Deal Watch: Anacor Purchase Marks Pfizer's Post-Allergan Bolt-On Strategy

Celgene pays Agios $200m up front for collaboration in immuno-oncology. Biogen inks pacts with Regenxbio and Penn to apply AAV technology to its developing gene-therapy program.